Regulation of the dopamine transporter - Addiction Research ...
Regulation of the dopamine transporter - Addiction Research ...
Regulation of the dopamine transporter - Addiction Research ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Schmitt & Reith DAT <strong>Regulation</strong><br />
<strong>the</strong> arachidonic acid pathway. Eur. J. Pharmacol. 315:<br />
345–354.<br />
72. Ingram, S.L. & S.G. Amara. 2000. Arachidonic acid<br />
stimulates a novel cocaine-sensitive cation conductance<br />
associated with <strong>the</strong> human <strong>dopamine</strong> <strong>transporter</strong>. J.<br />
Neurosci. 20: 550–557.<br />
73. Chen, N., M. Appell, J.L. Berfield & M.E. Reith. 2003.<br />
Inhibition by arachidonic acid and o<strong>the</strong>r fatty acids <strong>of</strong><br />
<strong>dopamine</strong> uptake at <strong>the</strong> human <strong>dopamine</strong> <strong>transporter</strong>.<br />
Eur. J. Pharmacol. 478: 89–95.<br />
74. Reese, E.A., J.R. Bunzow, S. Arttamangkul, et<br />
al. 2007. Trace amine-associated receptor 1 displays<br />
species-dependent stereoselectivity for isomers<br />
<strong>of</strong> methamphetamine, amphetamine, and parahydroxyamphetamine.<br />
J. Pharmacol. Exp. Ther. 321:<br />
178–186.<br />
75. Giambalvo, C.T. 2004. Mechanisms underlying <strong>the</strong><br />
effects <strong>of</strong> amphetamine on particulate PKC activity.<br />
Synapse 51: 128–139.<br />
76. Parnas, M.L. & R.A. Vaughan. 2008. Molecular structure<br />
and composition <strong>of</strong> <strong>dopamine</strong> <strong>transporter</strong>s. In<br />
Dopamine Transporters: Chemistry, Biology and Pharmacology.<br />
M.L. Trudell & S. Izenwasser, Eds.: 73–95.<br />
Wiley. Hoboken, NJ.<br />
77. Carvelli, L., J.A. Morón, K.M. Kahlig, et al. 2002. PI3kinase<br />
regulation <strong>of</strong> <strong>dopamine</strong> uptake. J. Neurochem.<br />
81: 859–869.<br />
78. Lin, Z., P.W. Zhang, X. Zhu, et al. 2003. Phosphatidylinositol<br />
3-kinase, protein kinase C, and MEK1/2 kinase<br />
regulation <strong>of</strong> <strong>dopamine</strong> <strong>transporter</strong>s (DAT) require Nterminal<br />
DAT phosphoacceptor sites. J. Biol. Chem. 278:<br />
20162–20170.<br />
79. Lute,B.J.,H.Khoshbouei,C.Saunders,et al. 2008. PI3K<br />
signaling supports amphetamine-induced <strong>dopamine</strong><br />
efflux. Biochem. Biophys. Res. Commun. 372: 656–661.<br />
80. Pearson, G., F. Robinson, T. Beers Gibson, et al. 2001.<br />
Mitogen-activated protein (MAP) kinase pathways:<br />
regulation and physiological functions. Endocr. Rev. 22:<br />
153–183.<br />
81. Morón, J.A., I. Zakharova, J.V. Ferrer, et al. 2003.<br />
Mitogen-activated protein kinase regulates <strong>dopamine</strong><br />
<strong>transporter</strong> surface expression and <strong>dopamine</strong> transport<br />
capacity. J. Neurosci. 23: 8480–8488.<br />
82. Lu, L., E. Koya, H. Zhai, et al. 2006. Role <strong>of</strong> ERK in<br />
cocaine addiction. Trends Neurosci. 29: 695–703.<br />
83. Welchman, R., C. Gordon & R.J. Mayer. 2005. Ubiquitin<br />
and ubiquitin-like proteins as multifunctional signals.<br />
Nat. Rev. Mol. Cell Biol. 6: 599–609.<br />
84. Hicke, L. 2001. Protein regulation by monoubiquitin.<br />
Nat. Rev. Mol. Cell Biol. 2: 195–201.<br />
85. Hicke, L. & H. Riezman. 1996. Ubiquitination <strong>of</strong> a<br />
yeast plasma membrane receptor signals its ligandstimulated<br />
endocytosis. Cell 84: 277–287.<br />
86. Egner, R. & K. Kuchler. 1996. The yeast multidrug <strong>transporter</strong><br />
Pdr5 <strong>of</strong> <strong>the</strong> plasma membrane is ubiquitinated<br />
prior to endocytosis and degradation in <strong>the</strong> vacuole.<br />
FEBS Lett. 378: 177–181.<br />
87. Kolling, R. & S. Losko. 1997. The linker region <strong>of</strong> <strong>the</strong><br />
ABC-<strong>transporter</strong> Ste6 mediates ubiquitination and fast<br />
turnover <strong>of</strong> <strong>the</strong> protein. EMBO J. 16: 2251–2261.<br />
88. Hicke, L. 1997. Ubiquitin-dependent internalization<br />
and down-regulation <strong>of</strong> plasma membrane proteins.<br />
FASEB J. 11: 1215–1226.<br />
89. Miranda, M., C.C. Wu, T. Sorkina, et al. 2005. Enhanced<br />
ubiquitylation and accelerated degradation <strong>of</strong><br />
<strong>the</strong> <strong>dopamine</strong> <strong>transporter</strong> mediated by protein kinase<br />
C. J. Biol. Chem. 280: 35617–35624.<br />
90. Miranda, M., K.R. Dionne, T. Sorkina & A. Sorkin.<br />
2007. Three ubiquitin conjugation sites in <strong>the</strong> amino<br />
terminus <strong>of</strong> <strong>the</strong> <strong>dopamine</strong> <strong>transporter</strong> mediate protein<br />
kinase C-dependent endocytosis <strong>of</strong> <strong>the</strong> <strong>transporter</strong>.<br />
Mol. Biol. Cell 18: 313–323.<br />
91. Sorkina, T., M. Miranda, K.R. Dionne, et al. 2006. RNA<br />
interference screen reveals an essential role <strong>of</strong> Nedd4–2<br />
in <strong>dopamine</strong> <strong>transporter</strong> ubiquitination and endocytosis.<br />
J. Neurosci. 26: 8195–8205.<br />
92. Strait, K.A. & R. Kuczenski. 1986. Dopamine autoreceptor<br />
regulation <strong>of</strong> <strong>the</strong> kinetic state <strong>of</strong> striatal tyrosine<br />
hydroxylase. Mol. Pharmacol. 29: 561–569.<br />
93. Pothos, E.N., S. Przedborski, V. Davila, et al. 1998. D2-<br />
Like <strong>dopamine</strong> autoreceptor activation reduces quantal<br />
size in PC12 cells. J. Neurosci. 18: 5575–5585.<br />
94. Meiergerd, S.M., T.A. Patterson & J.O. Schenk. 1993.<br />
D2 receptors may modulate <strong>the</strong> function <strong>of</strong> <strong>the</strong> striatal<br />
<strong>transporter</strong> for <strong>dopamine</strong>: kinetic evidence from<br />
studies in vitro and in vivo. J. Neurochem. 61: 764–<br />
767.<br />
95. Cass, W.A. & G.A. Gerhardt. 1994. Direct in vivo<br />
evidence that D2 <strong>dopamine</strong> receptors can modulate<br />
<strong>dopamine</strong> uptake. Neurosci. Lett. 176: 259–263.<br />
96. Zapata, A. & T.S. Shippenberg. 2002. D(3) receptor<br />
ligands modulate extracellular <strong>dopamine</strong> clearance in<br />
<strong>the</strong> nucleus accumbens. J. Neurochem. 81: 1035–1042.<br />
97. Mayfield, R.D. & N.R. Zahniser. 2001. Dopamine<br />
D2 receptor regulation <strong>of</strong> <strong>the</strong> <strong>dopamine</strong> <strong>transporter</strong><br />
expressed in Xenopus laevis oocytes is voltageindependent.<br />
Mol. Pharmacol. 59: 113–121.<br />
98. Wu, Q., M.E. Reith, Q.D. Walker, et al. 2002. Concurrent<br />
autoreceptor-mediated control <strong>of</strong> <strong>dopamine</strong><br />
release and uptake during neurotransmission: an<br />
Ann. N.Y. Acad. Sci. 1187 (2010) 316–340 c○ 2010 New York Academy <strong>of</strong> Sciences. 337